Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study
Anthropometry (1)
- BodyMassIndex - Body mass index of participant, calculated from measured height and weight (phv00173926.v1.p1)
Biomarkers (6)
- DiastolicBloodPressure - Diastolic blood pressure of participant, calculated from three measurements (phv00173928.v1.p1)
- fastingHDLCholesterol - Fasting hdl cholesterol, measured by Quest diagnostics (phv00173932.v1.p1)
- fastingLDLCholesterol - Fasting ldl cholesterol, measured by Quest diagnostics (phv00173933.v1.p1)
- fastingTotalCholesterol - Fasting total cholesterol, measured by Quest diagnostics (phv00173931.v1.p1)
- fastingTriglycerides - Fasting triglycerides, measured by Quest diagnostics (phv00173930.v1.p1)
- SystolicBloodPressure - Systolic blood pressure of participant, calculated from three measurements (phv00173927.v1.p1)
Demographics (2)
- AGE - Age participant began study (clinic visit 1) (phv00173924.v1.p1)
- SEX - Gender of participant (phv00173925.v1.p1)
Other (27)
- CONSENT - Consent group (phv00173920.v1.p1)
- cv2MaxAggrPRPAA - Post plavix/pre aspirin platelet rich plasma max aggregation of arachidonic acid (phv00173950.v1.p1)
- cv2MaxAggrPRPADP20 - Post plavix/pre aspirin platelet rich plasma max aggregation of ADP 20 ug/ml (phv00173947.v1.p1)
- cv2MaxAggrPRPColl2 - Post plavix/pre aspirin platelet rich plasma max aggregation of collagen 2 ug/ml (phv00173948.v1.p1)
- cv2MaxAggrPRPEpi - Post plavix/pre aspirin platelet rich plasma max aggregation of Epi (phv00173949.v1.p1)
- cv2MaxAggrWholeBloodAA - Post plavix/pre aspirin whole blood max aggregation of arachidonic acid (phv00173938.v1.p1)
- cv2MaxAggrWholeBloodADP20 - Post plavix/pre aspirin whole blood max aggregation of ADP 20 ug/ml (phv00173937.v1.p1)
- cv2MaxAggrWholeBloodColl1 - Post plavix/pre aspirin whole blood max aggregation of collagen 1 ug/ml (phv00173939.v1.p1)
- cv3MaxAggrPRPAA - Post plavix/post aspirin platelet rich plasma max aggregation of arachidonic acid (phv00173954.v1.p1)
- cv3MaxAggrPRPADP20 - Post plavix/post aspirin platelet rich plasma max aggregation of ADP 20 ug/ml (phv00173951.v1.p1)
- cv3MaxAggrPRPColl2 - Post plavix/post aspirin platelet rich plasma max aggregation of collagen 2 ug/ml (phv00173952.v1.p1)
- cv3MaxAggrPRPEpi - Post plavix/post aspirin platelet rich plasma max aggregation of Epi (phv00173953.v1.p1)
- cv3MaxAggrWholeBloodAA - Post plavix/post aspirin whole blood max aggregation of arachidonic acid (phv00173941.v1.p1)
- cv3MaxAggrWholeBloodADP20 - Post plavix/post aspirin whole blood max aggregation of ADP 20 ug/ml (phv00173940.v1.p1)
- cv3MaxAggrWholeBloodColl1 - Post plavix/post aspirin whole blood max aggregation of collagen 1 ug/ml (phv00173942.v1.p1)
- preMaxAggrPRPAA - Baseline platelet rich plasma max aggregation of arachidonic acid (phv00173946.v1.p1)
- preMaxAggrPRPADP20 - Baseline platelet rich plasma max aggregation of ADP 20 ug/ml (phv00173943.v1.p1)
- preMaxAggrPRPColl2 - Baseline platelet rich plasma max aggregation of collagen 2 ug/ml (phv00173944.v1.p1)
- preMaxAggrPRPEpi - Baseline platelet rich plasma max aggregation of Epi (phv00173945.v1.p1)
- preMaxAggrWholeBloodAA - Baseline whole blood max aggregation of arachidonic acid (phv00173935.v1.p1)
- preMaxAggrWholeBloodADP20 - Baseline whole blood max aggregation of ADP 20 ug/ml (phv00173934.v1.p1)
- preMaxAggrWholeBloodColl1 - Baseline whole blood max aggregation of collagen 1 ug/ml (phv00173936.v1.p1)
- SAMPID - Sample ID (phv00173922.v1.p1)
- SUBJID - De-identified subject ID (phv00173923.v1.p1)
- SUBJID - Subject ID (phv00173919.v1.p1)
- SUBJID - Subject ID (phv00173921.v1.p1)
- waistCircumference - Waist circumference of participant (phv00173929.v1.p1)